Remogliflozin etabonate T34286
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Remogliflozin etabonate (GSK 189075A, GSK 189075) is an SGLT2 inhibitor, the prodrug of regaliflozin. Remogliflozin inhibits the sodium-glucose transporter (SGLT), which are responsible for glucose reabsorption in the kidney. Blocking this transporter cau
CAS nr:
442201-24-3
Purity:
98%
Molecular Weight:
522,6
SMILES:
O[C@H]([C@H]([C@@H]([C@@H](COC(OCC)=O)O1)O)O)[C@@H]1OC2=NN(C(C)C)C(C)=C2CC3=CC=C(OC(C)C)C=C3
Formula:
C26H38N2O9
Pathway:
Target:
